Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Calibration × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1

Interventions

pembrolizumab 559 Specimen Handling 455 Carboplatin 444 Magnetic Resonance Spectroscopy 421 Cisplatin 400 Cyclophosphamide 398 Radiotherapy 316 Gemcitabine 311 Bevacizumab 306 Paclitaxel 297 Biopsy 255 Drug Therapy 250 venetoclax 228 Nivolumab 227 Capecitabine 226 Oxaliplatin 225 fludarabine 222 Injections 211 Docetaxel 203 Fluorouracil 195 Dexamethasone 189 Radiosurgery 165 Rituximab 160 Pemetrexed 158 Standard of Care 146 durvalumab 144 atezolizumab 141 130-nm albumin-bound paclitaxel 135 Leucovorin 133 Etoposide 133

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07483723 2026-03-19

PROGLYSOPK

Centre Hospitalier Universitaire, Amiens

Phase NA Recruiting

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡